BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22776235)

  • 1. Individualized leukemia cell-population profiles in common B-cell acute lymphoblastic leukemia patients.
    Yu JH; Dong JT; Jia YQ; Jiang NG; Zeng TT; Xu H; Mo XM; Meng WT
    Chin J Cancer; 2013 Apr; 32(4):213-23. PubMed ID: 22776235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development-associated immunophenotypes reveal the heterogeneous and individualized early responses of adult B-acute lymphoblastic leukemia.
    Li HF; Meng WT; Jia YQ; Jiang NG; Zeng TT; Jin YM; Huang QR; Li X; Xu H; Mo XM
    Medicine (Baltimore); 2016 Aug; 95(34):e4128. PubMed ID: 27559941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD19 negative precursor B acute lymphoblastic leukemia (B-ALL)-Immunophenotypic challenges in diagnosis and monitoring: A study of three cases.
    Ghodke K; Bibi A; Rabade N; Patkar N; Subramanian PG; Kadam PA; Badrinath Y; Ghogale S; Gujral S; Tembhare P
    Cytometry B Clin Cytom; 2017 Jul; 92(4):315-318. PubMed ID: 27018867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
    van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
    Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental hierarchy during early human B-cell ontogeny after autologous bone marrow transplantation using autografts depleted of CD19+ B-cell precursors by an anti-CD19 pan-B-cell immunotoxin containing pokeweed antiviral protein.
    Uckun FM; Haissig S; Ledbetter JA; Fidler P; Myers DE; Kuebelbeck V; Weisdorf D; Gajl-Peczalska K; Kersey JH; Ramsay NK
    Blood; 1992 Jun; 79(12):3369-79. PubMed ID: 1375851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic importance of CD179a/b as markers of precursor B-cell lymphoblastic lymphoma.
    Kiyokawa N; Sekino T; Matsui T; Takenouchi H; Mimori K; Tang WR; Matsui J; Taguchi T; Katagiri YU; Okita H; Matsuo Y; Karasuyama H; Fujimoto J
    Mod Pathol; 2004 Apr; 17(4):423-9. PubMed ID: 14976526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotypic challenges in diagnosis of CD79a negativity in a patient with B acute lymphoblastic leukemia harboring intrachromosomal amplification of chromosome 21: a case report.
    Berhili A; Bensalah M; ElMalki J; Elyagoubi A; Seddik R
    J Med Case Rep; 2021 Oct; 15(1):531. PubMed ID: 34706776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of leukemic cells in CD2/CD19 double positive acute lymphoblastic leukemia.
    Manabe A; Mori T; Ebihara Y; Koyama T; Okuyama I; Hosoya R; Kaneko M; Ishimoto K; Nakahata T; Nakazawa S
    Int J Hematol; 1998 Jan; 67(1):45-52. PubMed ID: 9594444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotypic Modulation of the Blast Cells in Childhood Acute Lymphoblastic Leukemia Minimal Residual Disease Detection.
    Burnusuzov HA; Spasova MI; Murdjeva MA; Stoyanova AA; Mumdziev IN; Kaleva VI; Belcheva MI; Bosheva MN
    Folia Med (Plovdiv); 2016 Mar; 58(1):28-35. PubMed ID: 27383875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364.
    Czuczman MS; Dodge RK; Stewart CC; Frankel SR; Davey FR; Powell BL; Szatrowski TP; Schiffer CA; Larson RA; Bloomfield CD
    Blood; 1999 Jun; 93(11):3931-9. PubMed ID: 10339502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The features and significance of immunophenotyping in adult acute leukemia].
    Pei MF; Zhang GS; Xiao L
    Hunan Yi Ke Da Xue Xue Bao; 2000 Jun; 25(3):262-4. PubMed ID: 12212161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biphenotypic leukemic lymphocyte precursors in CD2+CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues.
    Uckun FM; Muraguchi A; Ledbetter JA; Kishimoto T; O'Brien RT; Roloff JS; Gajl-Peczalska K; Provisor A; Koller B
    Blood; 1989 Mar; 73(4):1000-15. PubMed ID: 2784064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
    DiGiuseppe JA; Fuller SG; Borowitz MJ
    Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Leukemia-associated immunophenotypes in 415 childhood and adult patients with B lineage acute lymphoblastic leukemia by multiparametric flow cytometry analysis].
    Liu YR; Chen SS; Chang Y; Fu JY; Zhang LP; Wang H; Li LD; Zhu HH; Liu GL; Lu DP; Huang XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):853-7. PubMed ID: 17096875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of the t(9;22), t(12;21), and DNA hyperdiploid content with immunophenotype and proliferative rate of leukemic B-cells of pediatric patients with B-cell acute lymphoblastic leukemia].
    Quijano SM; Torres MM; Vásquez LE; Cuéllar GE; Romero ML; Martín EL; Linares A; Castaño S; Sarmiento IC; Cabrera E; Uribe GI; Andrade RE; Saavedra CE
    Biomedica; 2013; 33(3):468-86. PubMed ID: 24652183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD10 and CD19 fluorescence intensity of B-cell precursors in normal and leukemic bone marrow. Clinical characterization of CD10(+strong) and CD10(+weak) common acute lymphoblastic leukemia.
    Rego EM; Tone LG; Garcia AB; Falcão RP
    Leuk Res; 1999 May; 23(5):441-50. PubMed ID: 10374858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Minimal residual disease monitoring by flow cytometry in children with acute lymphoblastic leukemia].
    Popov AM; Verzhbitskaia TIu; Tsaur GA; Shorikov EV; Savel'ev LI; Tsvirenko SV; Fechina LG
    Klin Lab Diagn; 2010 Aug; (8):36-41. PubMed ID: 20886718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunophenotypic aberrancy in adult acute lymphoblastic leukemia.
    Ross CW; Stoolman LM; Schnitzer B; Schlegelmilch JA; Hanson CA
    Am J Clin Pathol; 1990 Nov; 94(5):590-9. PubMed ID: 2239822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.